Skip to main content

Bruker Wins $10M DOD Contract to Provide Ion Trap Mass Specs for Biological Defense

NEW YORK, Sept. 18 — Bruker Daltonics has said that prior to the terrorist attacks here and in Washington last week it had been awarded a $10 million US Department of Defense contract to supply ion trap mass spectrometers for chemical and biological defense. The company said it expects revenues from the contract to be generated over five quarters from 2002 to 2003. 

The US Army ordered Bruker’s advanced Chemical Biological Mass Spectrometers, which are primarily used for the detection of biological warfare agents. Mass spectrometers are contained in each of the Army's mobile units known as Biological Integrated Detection Systems. Each unit or vehicle consist of a lightweight multipurpose shelter mounted on a dedicated vehicle and equipped with a biological detection suite that employs complementary technologies to detect large area biological attacks. The system contains equipment that links aerodynamic particle sizing, bioluminescence/fluorescence, flow cytometry, mass spectrometry, and immunoassay technologies to increase detection confidence. 

Each of Bruker’s specially designed chemical/biological mass spec instruments is an integrated and fully automatic bioanalytical system that consists of air sampling devices, substance concentrator and dissociation modules, as well as a rugged, mobile ion trap mass spectrometer. After the biological or chemical agents are detected by the mass spectrometer, Bruker’s  bioinformatics  software is used for a final classification. 

Frank Laukien, president and CEO of Bruker Daltonics, said in a statement: “This significant order further validates our strategy of deploying integrated systems based on mass spectrometry for both life-science research and drug discovery, as well as for chemical and biological detection in security, defense, and anti-terrorism applications. While we are not raising our revenue and EPS estimates, this large contract gives additional visibility to our financial projections for 2002 and 2003.”


The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.